{"id":34679,"date":"2016-11-03T17:26:18","date_gmt":"2016-11-03T09:26:18","guid":{"rendered":"http:\/\/www.chinamoneynetwork.com\/?p=57268"},"modified":"2016-11-03T17:26:18","modified_gmt":"2016-11-03T09:26:18","slug":"venture-backed-bgi-suffers-ipo-blow-as-regulators-terminate-review","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2016\/11\/03\/venture-backed-bgi-suffers-ipo-blow-as-regulators-terminate-review\/","title":{"rendered":"Venture-Backed BGI Suffers IPO Blow As Regulators Terminate Review"},"content":{"rendered":"<img width=\"580\" height=\"427\" src=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare-10.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"healthcare\" style=\"display: block; margin: auto; margin-bottom: 5px;\" srcset=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare-10.jpg 580w, http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare-10-300x221.jpg 300w\" sizes=\"(max-width: 580px) 100vw, 580px\" \/>The IPO application of Chinese genomics powerhouse BGI's bid to list on the Chi-Next board of the Shenzhen Stock Exchange has been terminated, as Chinese securities regulator cited incomplete documentation as a reason for inability to proceed with its review. The event adds yet another twist to BGI's pursuit of a stock float, after years [&#8230;]<p><br>Visit <a href=\"http:\/\/www.chinamoneynetwork.com\/\" title=\"China Money Network\"><b>ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter <a href=\"http:\/\/www.twitter.com\/chinamoneypod\" title=\"Follow China Money Network on Twitter\">@chinamoneypod<\/a> subscribe to all episodes on <a href=\"http:\/\/www.itunes.com\/podcast?id=451002399\" title=\"Download and listen to China Money Podcast on iTunes\">iTunes<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"580\" height=\"427\" src=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare-10.jpg\" alt=\"healthcare\">The IPO application of Chinese genomics powerhouse BGI's bid to list on the Chi-Next board of the Shenzhen Stock Exchange has been terminated, as Chinese securities regulator cited incomplete documentation as a reason for inability to proceed with its review. The event adds yet another twist to BGI's pursuit of a stock float, after years [&hellip;]<\/p>\n<p>Visit <a href=\"http:\/\/www.chinamoneynetwork.com\/\" title=\"China Money Network\"><b>ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter <a href=\"http:\/\/www.twitter.com\/chinamoneypod\" title=\"Follow China Money Network on Twitter\">@chinamoneypod<\/a> subscribe to all episodes on <a href=\"http:\/\/www.itunes.com\/podcast?id=451002399\" title=\"Download and listen to China Money Podcast on iTunes\">iTunes<\/a>.<\/p>\n","protected":false},"author":151,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[194],"tags":[5436,7593,2353],"class_list":["post-34679","post","type-post","status-publish","format-standard","hentry","category-news-chinese-law","tag-exits","tag-fund-news","tag-ipo"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/151"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=34679"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34679\/revisions"}],"predecessor-version":[{"id":34680,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34679\/revisions\/34680"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=34679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=34679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=34679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}